anmelden
OMX Nordic 40
2.633,94
PKT
+21,52
PKT
+0,82
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.04.20 | Volvo (B) Neutral | UBS AG | |
| 24.04.20 | Volvo (B) buy | Citigroup Corp. | |
| 24.04.20 | Volvo (B) buy | Deutsche Bank AG | |
| 23.04.20 | Volvo (B) Neutral | JP Morgan Chase & Co. | |
| 23.04.20 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 23.04.20 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.04.20 | Ericsson (Telefon L.M.Ericsson) (B) buy | Citigroup Corp. | |
| 23.04.20 | Ericsson (Telefon L.M.Ericsson) (B) buy | Kepler Cheuvreux | |
| 23.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 22.04.20 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 22.04.20 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 21.04.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 21.04.20 | AstraZeneca buy | Kepler Cheuvreux | |
| 20.04.20 | Ericsson (Telefon L.M.Ericsson) (B) overweight | JP Morgan Chase & Co. | |
| 17.04.20 | Novo Nordisk buy | UBS AG | |
| 17.04.20 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 17.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 17.04.20 | Ericsson (Telefon L.M.Ericsson) (B) Outperform | Credit Suisse Group | |
| 16.04.20 | Volvo (B) Conviction Buy List | Goldman Sachs Group Inc. | |
| 16.04.20 | Nokia Equal weight | Barclays Capital | |
| 16.04.20 | Volvo (B) Hold | HSBC | |
| 16.04.20 | ABB (Asea Brown Boveri) Hold | HSBC | |
| 15.04.20 | A.P. Moeller - Maersk A-S (B) kaufen | Credit Suisse Group | |
| 15.04.20 | Novo Nordisk buy | UBS AG | |
| 15.04.20 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 15.04.20 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 15.04.20 | Novo Nordisk Outperform | Bernstein Research | |
| 15.04.20 | Hennes Mauritz (H M, H&M) overweight | Barclays Capital | |
| 14.04.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 14.04.20 | AstraZeneca buy | Deutsche Bank AG | |
| 14.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 14.04.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 09.04.20 | AstraZeneca overweight | Barclays Capital | |
| 09.04.20 | Novo Nordisk overweight | Barclays Capital | |
| 09.04.20 | Nokia buy | UBS AG | |
| 08.04.20 | Nokia buy | Deutsche Bank AG | |
| 08.04.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 08.04.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital |